All Stories

  1. Positive Self-Relation Scale – development and psychometric properties
  2. Relation of personality factors and life events to waist/height ratio and percentage of visceral fat in women and men
  3. Quality of life, self-stigma, and coping strategies in patients with neurotic spectrum disorders: a cross-sectional study
  4. EEG correlates of induced anxiety in obsessive–compulsive patients: comparison of autobiographical and general anxiety scenarios
  5. Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients – a cross-sectional study
  6. The differences between patients with panic disorder and healthy controls in psychophysiological stress profile
  7. Self-stigma and treatment effectiveness in patients with anxiety disorders – a mediation analysis
  8. Quality of life and coping strategies of outpatients with a depressive disorder in maintenance therapy – a cross-sectional study
  9. Coping, schemas, and cardiovascular risks – study protocol
  10. Comorbidity of schizophrenia and social phobia – impact on quality of life, hope, and personality traits: a cross sectional study
  11. Which psychological, psychophysiological, and anthropometric factors are connected with life events, depression, and quality of life in patients with cardiovascular disease
  12. Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study
  13. Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders – a cross-sectional study
  14. Self-stigma and schizophrenia: a cross-sectional study
  15. Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder
  16. Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders
  17. Self-stigma and quality of life in patients with depressive disorder: a cross-sectional study
  18. Delirium as a complication of the surgical intensive care
  19. Self-stigma in borderline personality disorder – cross-sectional comparison with schizophrenia spectrum disorder, major depressive disorder, and anxiety disorders
  20. Quality of life in borderline patients comorbid with anxiety spectrum disorders – a cross-sectional study
  21. Connection between self-stigma, adherence to treatment, and discontinuation of medication
  22. Psychological factors and treatment effectiveness in resistant anxiety disorders in highly comorbid inpatients
  23. Unmet needs of bipolar disorder patients
  24. Coping strategies and self-stigma in patients with schizophrenia-spectrum disorders
  25. Cognitive deficits in patients with obsessive–compulsive disorder – electroencephalography correlates
  26. Are self-stigma, quality of life, and clinical data interrelated in schizophrenia spectrum patients? A cross-sectional outpatient study
  27. Cognitive behavioral therapy in pharmacoresistant obsessive–compulsive disorder
  28. Quality of life and parental styles assessed by adolescents suffering from inflammatory bowel diseases and their parents
  29. Coping strategies and quality of life in schizophrenia: cross-sectional study
  30. Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities
  31. Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders
  32. The circadian system of patients with bipolar disorder differs in episodes of mania and depression
  33. Violent victimization of adult patients with severe mental illness: a systematic review
  34. P.8.b.008 Self-stigmatisation and adherence to treatment
  35. P.4.d.006 Predictors of therapeutic response in patients with obsessive–compulsive disorder, panic disorder and social phobia
  36. Perspectives on perceived stigma and self-stigma in adult male patients with depression
  37. EPA-1336 – Ethical questions and dilemmas in psychotherapy
  38. EPA-1341 – Ethics in cognitive behavioral therapy supervision
  39. EPA-1418 – Therapeutic letters using for emotional processing
  40. EPA-1311 - Training of the cognitive behavioral supervision
  41. EPA-1320 - CBT with the schema therapy in patients with personality disorders
  42. EPA-1424 – Using imagery in emotional work
  43. EPA-1423 – Integration of schema therapy for cognitive behavioral therapist
  44. EPA-1419 – Schema modes, transference and countertransference
  45. EPA-1347 – Predictors of therapeutic response in selected anxiety disorders
  46. EPA-1344 – Countertransference, schema modes and ethical considerations in cognitive behavioral therapy
  47. EPA-1285 - Relation between beliefs and attituted toward supervision in cognitive behavioral therapy and competencies of the trainees in cognitive behavioral training
  48. EPA-1272 – Internet based psychoeducative CBT program for the bipolar patients treated with thymostabilisers-6 months follow up
  49. EPA-1296 - Relationship between internalized stigma and treatment efficacy in mixed neurotic spectrum and depressive disorders
  50. Alcohol withdrawal delirium - diagnosis, course and treatment
  51. Internet Psychoeducation for Bipolar Affective Disorder: Basis for Preparation and First Experiences
  52. Standardized low-resolution electromagnetic tomography in obsessive–compulsive disorder—A replication study
  53. 929 – Principles of supervision in cognitive behavioural therapy
  54. 1312 – Interparental conflict and adolescent suicidality
  55. 1253 – Etical aspects of cognitive behavioral therapy supervision
  56. 930 – Transference and countertransference in cognitive behavioral therapy
  57. 927 – Countertransference and supervision in cognitive behavioral therapy
  58. Treatment effect prediction in panic disorder patients - fmri study
  59. 1241 – Beliefs and attituted toward supervision in cognitive behavioral therapy in different stages of CBT training
  60. 1932 – Pharmacotherapy of borderline personality disorder during the time
  61. 1355 – Borderline personality disorder and schemas orientate words processing - fmri study
  62. 2317 – Stigmatization of psychiatric patients by medical students
  63. 838 – Level of dissociation in patients with bipolar affective disorder compared with healthy controls
  64. 1517 – Sloreta findings in patients with panic disorder - differences between responders and non-responders to combined cbt and pharmacotherapy
  65. 1221 – Rescripting or the traumatic or distresing stories from childhood in imagination
  66. 1263 – Internet based psychoeducative CBT program for bipolar patients treated with thymostabilisers
  67. 926 – Emotional processing in patients with affective, borderline and dissociative disorders
  68. 843 – Group cognitive behavioral therapy for patients with panic disorder
  69. 1228 – Regional metabolic brain requirements comparison in selected anxiety disorders
  70. 1232 – Psychoeducation for patients with bipolar affective disorder
  71. 833 – Depression and personality disorders - treatment findings
  72. 835 – Prediction of outcome in complex treatment program for pharmacoresistant panic disorder patients
  73. 834 – Fighting stigma of psychiatric disorders in czech republic
  74. 1226 – Changing the emotional schemas using writing letters to significant caregivers
  75. 832 – Predictors of outcome of complex in-patient therapeutic program for pharmacoresitant obsessive compulsive patients
  76. 850 – Panic disorder with and without personality disorders-therapeutic outcome of pharmacoresistant in-patients
  77. 840 – Heart rate variability in panic disorder patients before and after the therapy
  78. 839 – Sloreta findings in patients with panic disorder, changes after combined therapy - pilot study
  79. 841 – Comparison of quality of life between patients with bipolar afective disorder, schizophrenia and healthy controls
  80. 842 – Euthymic bipolar affective disorder patients and their heart rate variability
  81. 844 – Therapeutic response to intensive psychotherapeutic programs in patients with anxiety disorders
  82. 1222 – The quality of life of patients suffering from schizophrenia - a comparison with healthy controls
  83. 831 – Self-stigmatization and treatment outcome of pharmacoresistant patiens with anxiety disorders in komplex inpatients treatment program
  84. P.4.a.012 Treatment effect prediction of cognitive behavioural therapy in panic disorder patients – fMRI study
  85. P.1.b.001 Heart rate variability spectral analysis in patients with panic disorder compared with healthy controls
  86. P.4.e.002 Standardised LORETA findings in patients with panic disorder before and after cognitive behavioural therapy
  87. Self-reflection in cognitive behavioural therapy and supervision
  88. Fighting stigma of mental illness in midsize European countries
  89. Principles of supervision in cognitive behavioural therapy
  90. Comparison of Personality Characteristics in Parkinson Disease Patients With and Without Impulse Control Disorders and in Healthy Volunteers
  91. CS07-04 - Pharmacotherapy during long-term psychotherapy
  92. P-1166 - Rescripting or the traumatic or distresing stories from childhood in imagination
  93. P-788 - Sloreta findings in patients with panic disorder before and after treatment - case serie
  94. AS17-02 - Psychoeducation and psychotherapy of schizophrenia patients
  95. P-1164 - Transference and countertransference in cognitive behavioral therapy
  96. P-1163 - Principles of supervision in cognitive behavioural therapy
  97. O-46 - Group CBT of anxiety disorders
  98. P-392 - Delirium in surgery intensive unit
  99. W02-02 - Effects of group cognitive behavioral therapy with anxiety disorders
  100. AS17-01 - The quality of life of patients suffering from bipolar disorder - a comparison with schizophrenic patients and healthy controls
  101. P-187 - Bipolar affective disorder and dissociation - comparison with healthy controls
  102. P-1174 - Narrative cognitive behavior therapy for psychosis
  103. P-1325 - The quality of life of patients suffering from schizophrenia - a comparison with healthy controls
  104. P-935 - Augmentation of antidepressants with bright light therapyin patients with comorbid depression and borderline personality disorder
  105. P-142 - Heart rate variability spectral analysis in patients with panic disorder compared with healthy controls
  106. P-936 - Personality disorder influence the treatment of social phobia
  107. W02-01 - The cognitive and behavioral models of aniety disorders
  108. P-188 - Autonomic nervous system in euthymic patients with bipolar affective disorder
  109. P-1165 - Therapeutic letters - changing the emotional schemas using writing letters to significant caregivers
  110. P-140 - Level of dissociation predicts the therapeutic response to cognitive behavioral therapy in patients sufering with obsessive compulsive disorder resistant to psychopharmacscs
  111. P-141 - Influence of personality disorder on the treatment of panic disorder - comparison study
  112. P-143 - Predicting the therapeutic response to intensive psychotherapeutic programs in patients with anxiety disorders
  113. Psychoeducation for psychotic patients
  114. EEG source analysis in obsessive–compulsive disorder
  115. Bipolar affective disorder and dissociation – comparison with healthy controls
  116. The quality of life of patients suffering from schizophrenia – a comparison with healthy controls
  117. Cognitive impairment in bipolar disorder
  118. Is there any influence of personality disorder on the short term intensive group cognitive behavioral therapy of social phobia?
  119. Treatment effect of cognitive behavioral psychotherapy in panic disorder - fmri study
  120. Fighting stigma of psychiatric disorders in czech republic
  121. Parkinson's disease and predictors of impulse control disorders in MMPI-2
  122. Autonomic nervous system in euthymic patients with bipolar affective disorder
  123. The quality of life of patients suffering from schizophrenia - a comparison with healthy controls
  124. Catastrophic scenario in the treatment of hypochondriasis, OCD and anxiety disorders
  125. Comparison of the effect of pharmacotherapy and the combination of psychotherapy and pharmacotherapy in the treatment of depressive disorder
  126. P01-210-Bipolar affective disorder and dissociation – comparison with healthy controls
  127. Heart rate variability and dissociation in panic disorder
  128. The quality of life of patients suffering from bipolar disorder – a comparison with schizophrenic patients and healthy controls
  129. Emotional processing of traumatic emotions and early experiences using the therapeutic letters, role playing and imagination in borderline and other difficult patients
  130. Psychological aspects and psychotherapy of inflammatory bowel diseases and irritable bowel syndrome in children
  131. Augmentation of antidepressants with bright light therapy in patients with comorbid depression and borderline personality disorder
  132. Suicidal patients
  133. Transference and countertransference in cognitive behavioral therapy
  134. Obsessive compulsive disorder and dissociation - comparison with healthy controls
  135. Aggression in Borderline Personality Disorder
  136. Medial frontal and dorsal cortical morphometric abnormalities are related to obsessive-compulsive disorder
  137. The Change of Regional Brain Metabolism (18 FDG PET) in Panic Disorder During The Treatment with Cognitive Behavioral Therapy or Antidepressants
  138. Regional Metabolic Brain Requirements Comparison in Selected Anxiety Disorders - PD, OCD, PTSD, Agoraphobia
  139. Identification of Relation Between Uptake of 18FDG PET and Severity of Symptomatology in Panic Disorder
  140. Dissociative Disorders - Clinical Manifestation and Management
  141. Imaginative Death Experience in Hypochondriasis
  142. Stigmatization in anxiety disorders
  143. The effect of repetitive transcranial magnetic stimulation add on serotonin reuptake inhibitors in panic disorder
  144. The effect of repetitive transcranial magnetic stimulation on symptoms in obsessive compulsive disorder
  145. Moclobemide and cognitive behavioral therapy in the treatment of social phobia
  146. Low resolution brain electromagnetic tomography findings in panic disorder
  147. Influence of personality disorder on the treatment of panic disorder: Comparison study
  148. Is there any influence of personality disorder on the treatment of social phobia?
  149. Augmentation of antidepressants with bright light therapy in patients with comorbid depression and borderline personality disorder
  150. Imaginative death experience in hypochondriasis
  151. Using multimedial tools, role playing and videofeedback in the training of case management
  152. Brain 18FDG pet in panic disorder during the treatment with CBT or antidepressants
  153. Sleep disturbances in patients treated for panic disorder
  154. Chapter 46 Circadian rhythmicity: from basic science to clinical approach
  155. A COMPARATIVE TRIAL OF CHLORMETHIAZOLE, DIKALIUM-CLORAZEPATE AND FLUNITRAZEPAME IN THE TREATMENT OF DELIRIUM TREMENS